Amurka ta sayar da haƙƙin ƴan ƙasarta na shari'ar juriya ga babbar ƙungiyar masu fafutuka ta ƙasar, kuma Amurkawa yanzu suna ɗaukar kuɗin bayan Pharma ya sami ribar da aka samu.
Dokar PREP, wata doka ta 2005 da Sakataren HHS Alex Azar ya kira a farkon cutar, ta ba da garantin rigakafi "daga duk da'awar da ta haifar, taso daga, da ta shafi, ko sakamakon gudanarwa zuwa ko amfani da wani mutum na wani abin rufe fuska," gami da allurar mRNA.
A zahiri, wannan yana aiki azaman "katin fita daga kurkuku ga duk wanda ke da alaƙa da harbin Covid," kamar yadda Alex Berenson. ya bayyana a cikin rahotonsa na baya-bayan nan. Duk da yake samfuran Covid sun sami Pfizer sama da dala biliyan 50 a cikin 2022, Dokar PREP ta hana Amurkawa yin ƙarar rauni ko rashin da'a na likitanci da ke da alaƙa da fa'idar "takaddun matakan kariya."
Berenson yayi nazari akan lamura da dama a fadin kasar. A Oklahoma, wata mata ta yi iƙirarin cewa ta shiga kantin sayar da Walgreens don rigakafin mura, amma wata ma'aikaciya ta gudanar da rigakafin Covid ba tare da saninta ba. A Kansas, wani mai harhada magunguna ya yi zargin ya ba da harbin Covid ga ƙaramin yaro ba tare da izinin iyaye ba. A Arewacin Carolina, iyaye sun kawo kara lokacin da danta ya fito don gwajin Covid amma masu rigakafin sun ba shi RNA jab ba tare da izini ba. A karkashin dokar PREP, kotuna sun yi watsi da dukkan shari’o’insu.
Amma wannan lamarin bai iyakance ga martanin Covid ba.
Hannah Brusewitz, an haife ta a 1991, ta sha wahala fiye da 100 bayan da ta karbi maganinta na DTP, wanda ya haifar da lalacewar kwakwalwa ta dindindin. Kotun Koli ta ce ba za ta iya kai karar kamfanin da ke yin allurar ba saboda raunin da ta samu saboda wata garkuwar alhaki da Shugaba Reagan ya sanya wa hannu a cikin doka a shekarar 1986, yana mai gabatar da kara kan "dukkan da'awar da aka yi na rashin tsari kan masana'antun rigakafin da masu gabatar da kara suka kawo wadanda ke neman diyya don rauni ko mutuwa sakamakon illar rigakafin."
Tsarin shari'a mai nau'i biyu, wanda Big Pharma ke jin daɗin faɗuwar umarni ba tare da tsadar abin alhaki na doka ba, cin zarafi ne kai tsaye ga Dokar Haƙƙinmu. Daidai abin da aka ƙera Kwaskwarimar Bakwai don hanawa.
Rushewar Gyara ta Bakwai
Framers sun amince da Kwaskwarima na Bakwai, wanda ke ba wa Amurkawa yancin yin shari'ar juri, don kare 'yan ƙasa daga tasirin da bai dace ba na ikon kasuwanci wanda zai lalata tsarin shari'a don amfanin kansu.
Ba tunani bane ko fasaha; littattafai kira yana da “mahimmanci a kowace ƙasa mai ‘yanci,” yana gargaɗin “ɗan da aka haifa sosai” za su yi amfani da ikon shari’a, kuma za su kasance “na gabaɗaya, kuma a zahiri ma, don fifita waɗanda ke bayanin nasu.”
Sanarwar 'yancin kai ya lissafa kin amincewa da "fa'idodin shari'a ta juri" a matsayin korafe-korafen da ke haifar da juyin juya halin Musulunci, kuma Sir William Blackstone ya kira shari'ar juri " daukakar dokar Ingilishi," saboda rashin su zai haifar da tsarin shari'a da maza ke gudanarwa tare da "rashin son rai ga waɗanda suke da daraja da mutuncinsu."
Darajar Bakwai, a tare da haƙƙin sauyawa na biyar ga tsari na biyar, da aka yi aiki a matsayin doka wanda ke tilastawa ga Americanancin Amurka na daidaito a gaban doka. Amma hakan ya haifar da babbar matsala ga Big Pharma.
A 1985, da New York Times eulogized zamanin riba a cikin Pharmaceutical masana'antu. Hasashen ba zai iya zama mafi kuskure ba.
"Kwanakin daukaka sun ƙare don Magunguna,” in ji Gray Lady.” Labarin ya ambata gasa da kuma haƙƙin doka a matsayin alamun da ke nuna cewa “ba zato ba tsammani manyan kamfanonin ƙwayoyi sun sami kansu cikin irin matsalolin da suka addabi masana’antu marasa kyan gani na shekaru da yawa.”
"Ba makawa wasu [kamfanonin] za su fuskanci alhaki mai ban mamaki da kuma dogon shari'o'in kotu kan magungunan da aka amince da su wadanda daga baya suka zama marasa laifi," in ji dan jarida Winston Williams. rubuta.
Tabbas, kwanakin ɗaukaka ba su ƙare ga Big Pharma ba.
Daga 2000 zuwa 2018, kamfanonin harhada magunguna 35 sun ba da rahoton yawan kudaden shiga na dala tiriliyan 11.5. A binciken ya samu cewa wannan ya kasance "mafi girma fiye da sauran manyan kamfanoni na jama'a a lokaci guda." Kudin shiga na shekara-shekara na Pfizer ya tashi daga dala biliyan 3.8 a 1984 zuwa rikodi $ 100 biliyan a shekarar 2022. Kudaden da Amurka ke kashewa kan kiwon lafiya, kamar yadda aka auna a matsayin kashi na GDP, yana da fiye da ninki biyu a cikin shekaru 40 na ƙarshe.
Rushewar Kwaskwarimar Bakwai ya kasance mai mahimmanci ga wannan tsari. A ƙarshen karni na 20, kamfanonin rigakafin sun fara ba da fifiko ga ribar kamfanoni akan matsalolin tsaro. Misali, Wyeth (yanzu Pfizer), da sane ya tallata sigar mafi ƙarancin aminci na rigakafin DPT lokacin takaddun kamfani na ciki. ya nuna cewa "tsarin tsarkakewa" zai haifar da "Ƙaruwa mai yawa a cikin farashin ƙira."
Maimakon rage ribar riba, Wyeth da sauran kamfanonin harhada magunguna sun nemi Majalisa ta zartar da Dokar Rauni ta Yara ta Ƙasa ta 1986. NCVIA ta ƙididdige shawarwarin binciken, wanda Merck da Lederle suka bayar, wanda ya kawar da masu kera alluran rigakafi daga alhakin raunin rigakafin.
Garkuwar abin alhaki ya haifar da bunƙasa ga ribar kamfanoni, kuma kotuna sun ba shi girman kai. Bayan Dokar 1986, jadawalin rigakafin yara ya fashe daga alluran rigakafin da aka ba da shawarar guda uku (DTP, MMR, da polio) zuwa harbi 72. A baya, kwanakin ɗaukaka ba su fara ba don magunguna a cikin 1985. A ƙarƙashin sabuwar doka, gwamnati za ta iya ba da izinin harbi, da tabbatar da biliyoyin daloli a cikin kudaden shiga ga Merck, Pfizer, da sauran masana'antun magunguna, yayin da suke canja farashin kayayyakin su ga mai biyan haraji.
Sayar da Kwaskwarimar Bakwai
Ƙofar jujjuyawa tsakanin gwamnati da Big Pharma ta haifar da tsarin doka na maza waɗanda ke fifita "waɗanda suke da matsayinsu," kamar yadda Sir Blackstone ya yi gargaɗi.
A cikin 2018, Labaran Lafiya na Kaiser samu "Kusan tsofaffin ma'aikatan majalisa 340 yanzu suna aiki ga kamfanonin harhada magunguna ko kuma kamfanonin da ke neman shiga."
Alex Azar, Sakataren HHS da ke da alhakin aiwatar da Dokar PREP, shi ne shugaban sashin Amurka na Eli Lilly daga 2012 zuwa 2017. Scott Gottlieb ya yi murabus a matsayin Kwamishinan FDA a 2019 shiga Kwamitin Gudanarwa na Pfizer, inda ya ba da shawarar kulle-kulle da tantancewa a lokacin Covid, koda karfafa Twitter don kashe pro-alurar rigakafin likitocin da suka tattauna rigakafi na halitta.
Mai ba da shawara a Fadar White House Steve Richetti ya yi aiki a matsayin mai fafutuka na tsawon shekaru ashirin kafin ya shiga gwamnatin Biden. Abokan cinikinsa sun haɗa da Novartis, Eli Lilly, da Pfizer. The New York Times ya kwatanta shi a matsayin "daya daga cikin masu ba da shawara [Biden] masu aminci, kuma wani Mista Biden zai kusan juya zuwa lokacin rikici ko kuma cikin mawuyacin hali."
Ƙofar da ke jujjuyawa ta kasance tare da yunƙurin talla da tallan da ba a taɓa gani ba. Daga 2020 zuwa 2022, masana'antar magunguna da samfuran kiwon lafiya ya kashe dala biliyan 1 wajen yin lobbying. Ga mahallin mahallin, wannan ya ninka fiye da sau biyar banki kasuwanci masana'antu da aka kashe akan lobbying a lokaci guda. A cikin waɗancan shekaru ukun, Big Pharma ya kashe kuɗi fiye da na mai, gas, barasa, cãca, noma, Da kuma tsaro masana'antu a hade.
Ƙoƙarin tasirin tasirin ya faɗaɗa ga ƴan ƙasa da gidajen labarai kuma. Kamfanonin harhada magunguna kashe kudi sosai akan talla da tallace-tallace fiye da bincike da haɓakawa (R&D). A cikin 2020, Pfizer ya kashe dala biliyan 12 akan tallace-tallace da tallace-tallace da dala biliyan 9 akan R&D. A wannan shekarar, Johnson & Johnson ya ba da dala biliyan 22 don tallace-tallace da tallace-tallace da dala biliyan 12 ga R&D.
Yunkurin masana'antar ya sami lada. Biliyoyin daloli a cikin tallace-tallace sun haifar da miliyoyin jama'ar Amurkawa shirye-shiryen da Pfizer ke ɗaukar nauyin. The latsa tallata samfuran su kuma ba kasafai aka ambata tarihin Big Pharma na arzurta zalunci, zamba, Da kuma roƙon laifi.
Wannan ita ce cibiyar kamfen ɗin tallace-tallace na duniya, wanda aka tsara don sarrafa kotuna, kafofin watsa labarai, da kuma fahimtar jama'a. A cikin Rahoton Shekara-shekara na Pfizer na 2022, Shugaba Albert Bourla ya jaddada muhimmancin abokan ciniki '"tabbataccen hasashe" na Pharmaceutical giant.
Bourla ya ce "2022 shekara ce mai cike da tarihi ga Pfizer, ba wai kawai ta fuskar kudaden shiga da kuma abin da aka samu a kowane kaso ba, wanda ya kasance mafi girma a cikin dogon tarihinmu," in ji Bourla. "Amma mafi mahimmanci, dangane da adadin marasa lafiya waɗanda ke da kyakkyawar fahimta game da Pfizer da aikin da muke yi."
Masana'antar ta sadaukar da biliyoyin daloli wajen murde Amurkawa wajen daukar kayayyakinta yayin da gwamnatinsu ta kwace musu hakkinsu na shari'a; 'yan kasa, ba tare da ikon yin la'akari da kamfanoni a gaban kotu ba, ci gaba da bayar da tallafi gwamnatin tarayya-pharmaceutical hegemon tare da harajin dalar su.
Kamar yadda aka lura a cikin Yadda Gwamnati ta kebe Big Pharma daga Alhaki: "A zahiri, gwamnatin tarayya ta sayar da doka ta bakwai ga babbar rundunar masu fafutuka a kasar nan.
-
Labarai daga Cibiyar Brownstone, ƙungiyar sa-kai da aka kafa a watan Mayu na 2021 don tallafawa al'umma da ke rage rawar tashin hankali a rayuwar jama'a.
Duba dukkan posts
